Skip to content
Home
Categories
Immune Checkpoint Inhibitors
T cells
PD-1
Melanoma
Breast Cancer
Cancer Vaccines
FDA
Immuno-Oncology
Therapies
Approved Drugs
Bavencio (Avelumab)
Imfinzi (Durvalumab)
Keytruda (Pembrolizumab)
Kymriah (Tisagenlecleucel)
Opdivo (Nivolumab)
Tecentriq (atezolizumab)
Unituxin (Dinutuximab)
Yervoy (Ipilimumab)
Yescarta (Axicabtagene Ciloleucel) – Formerly KTE-C19
Experimental Therapies
a
ABBV-181
ABBV-428
ABP798
Actimmune
Adagloxad Simolenin
ADU-741 (JNJ-64041809 )
ADXS-HER2
ADXS-PSA
AE37
AFM11
AFM13
Zalifrelimab (AGEN1884)
Balstilimab (AGEN2034)
ALKS 4230
AlloStim
AM0010 (Pegilodecakin)
AMG 211 (MEDI-565)
AMG 330
AMG 420
APVO414 (MOR209/ES414)
AST-VAC1
ATA520
AutoSynVax
b-c
Idecaptagene Cicleucel (Ide-Cel; Previously bb2121)
BGB324 (bemcentinib)
Tislelizumab (Previously BGB-A317)
Blincyto (blinatumomab)
Biropepimut-S (GL-0817)
BMS 986178
BPX-501
BPX-601
BriaVax
Canakinumab
Cavatak (Coxsackievirus – CVA21)
CBT-501 (genolimzumab)
CBT-502
Cergutuzumab Amunaleukin
CMP-001
CMD-003 (Baltaleucel-T)
CRISPR/Cas9 and Cancer
CRS-207
CS1001
CX-072
D-F
DCVax
DI-Leu16-IL2
DNX-2401
DPX-E7
DPX-Survivac
Enadenotucirev
EP-101 STEMVAC
ETBX-011
ETBX-021
FAZ053
Flotetuzumab (MGD006)
G-I
GALE-301
Galinpepimut-S
Ganitumab
GBR 1342
GI-6207
GI-6301
GL-ONC1
Gliovac (ERC1671)
GP2
GRN-1201
GSK3174998
GWN323
HF10
ICT-107
ICT-121
IGN002
IMCgp100
IMP701
INCAGN1949
INO-1400
INO-3106
INO-5150
INO-9012
J-L
JCAR014
JCAR017
JNJ-61186372
JNJ-63709178
JNJ-63723283
JNJ-64041757 (ADU-214)
JTX-2011
KN035
LAG525 (IMP701)
LAMP-pp65-DC Vaccine
Lirilumab (IPH2102/BMS-986015)
LOAd703
LV305
M-O
M7824
MAGE-A10 T-Cell Therapy
MBG453
MDNA55
MEDI0457
MEDI0562
MEDI0680
MGA012
MGD009
MK-4166
Mogamulizumab
MVA-BN Brachyury
MVI-118
NEO-PV-01
NeuVax (Nelipepimut-S)
NKR-2
NKTR-214
NY-ESO TCR
OncoVAX
ONCOS-102
P-S
PAN-301-1
PDR001
PDS0101
PF-04518600
PF-06801591
PNK-007
ProscaVax
Provenge (Sipuleucel-T)
PVRIG
REGN2810 (SAR439684)
REGN3767
Relatlimab
Reolysin
RG7802
RG7828
Rocapuldencel-T
rSIFN-co
SHR-1210
SL-701
SurVaxM
T-Z
TT12
Tedopi (OSE-2101)
Telomelysin (OBP-301)
TG4010
TPIV 200
TPIV200
Traumakine
TRX518
TSR-022
TSR-042
Utomilumab
ValloVax
Varlilumab
VBI-1901
VGX-3100
Viagenpumatucel-L
Vigil
VX15
XmAb13676
COVID-19 Info
COVID-19 Updates
Search for:
Mail
Home
» Mail
[symposium-mail]
We use cookies
to enhance your experience on our website.
Privacy Policy
Accept